Table 5.
The frequency of the reported symptoms of long COVID-19 syndrome according to the time from the acute phase of the disease.
| Symptoms of the Long COVID-19 Syndrome | 12–24 Weeks N = 195 |
>24 Weeks N = 234 |
p |
|---|---|---|---|
| Fatigue/weakness, n (%) | 193 (98.97) | 234 (100.00) | 0.400 |
| Fatigue, Borg’s scale (pts.), M ± SD | 4.73 ± 2.59 | 4.66 ± 2.01 | 0.924 |
| Dyspnea, n (%) | 193 (98.97) | 233 (99.57) | 0.874 |
| Dyspnea, Borg’s scale (pts.), M ± SD | 3.27 ± 2.59 | 3.51 ± 2.61 | 0.334 |
| Cough, n (%) | 11 (5.64) | 28 (11.97) | 0.036 |
| Myalgia, n (%) | 187 (95.90) | 229 (97.86) | 0.368 |
| Chest pain, n (%) | 9 (4.62) | 16 (6.84) | 0.440 |
| Palpitations, n (%) | 21 (10.77) | 40 (17.09) | 0.084 |
| Increased/unstable blood pressure, n (%) | 5 (2.56) | 7 (2.99) | 0.979 |
| Concentration disorders/memory deterioration, n (%) | 129 (66.15) | 113 (48.29) | <0.001 |
| Depressed mood/sleep disturbance, n (%) | 61 (31.28) | 85 (36.32) | 0.320 |
| Loss/impaired smell, n (%) | 5 (2.56) | 5 (2.14) | 0.977 |
| Hair loss, n (%) | 11 (5.67) | 9 (3.86) | 0.516 |
| Dizziness, n (%) | 37 (18.97) | 41 (17.52) | 0.793 |
| Deterioration of eyesight and hearing, n (%) | 11 (5.64) | 12 (5.13) | 0.984 |
COVID-19—coronavirus disease 2019; Borg’s scale—Borg’s Rate of Perceived Exertion scale. Significant differences are in bold.